 Insiders Are Buying: A Signal for the Market Analysis of top insider purchases on May 11 — major players loaded up on $120+ million. Key points: — Genedx Holdings (WGS) — director invested $46.8 million. This is not just a purchase; it's confidence in the company's diagnosis. — Odyssey Therapeutics (ODTX) — two insiders totaling $30 million. Biotech with self-belief. — Pulse Biosciences (PLSE) — $13 million from top management. — ADP — director increased stake by 231%, buying $746k worth. When an insider triples their position, it's worth paying attention. What stands out: the main flow is into biotech (Genedx, Odyssey, Atara, Mobia, Pulse). The AI sector was not overlooked either — Starlink AI Acquisition received $2.2 million. Insiders vote with their money. When directors buy tens of millions, it carries more weight than any analytical reports. https://asibiont.com/